(Event Report)2nd Session of “Action on Health Technology” Series~Health Technology Implementation around the World: Learning from Netherlands~
date : 5/13/2016
The Netherlands has overcome various regulatory bottlenecks and policy barriers to become one of the leading nations in the field of health technology including telemedicine and healthcare ICT. In this session, Mr. Tas has not only presented the latest technology in health care and the current situation of the Netherlands, but also provided an insight into the Netherlands’ experiences of policy making in this field from policy formulation and negotiation to implementation, evaluation and revision/adjustment. This session provided an opportunity for an open multi-stakeholder discussion for effective policy development with experts including private, public and academic sectors.
Opening Remarks
Prof. Hiroaki Miyata of Keio University addressed 4 critical areas in which health technology will bring significant impact to; “Cost Effectiveness”, “Specialty”, “Space” and “Time”. Health technology will improve cost effectiveness and shorten waiting time for laboratory examination. Integration of information by specialists on cloud platform and utilization of cloud data to identify best and personalized care for each patient will soon be possible by health technology.
Presentation(Mr. Jeroen Tas)
In the challenging time for healthcare history, the current healthcare system fails to adjust to the changing landscape with rise of chronic diseases, and financial resource constraints. Mr. Tas presented 4 key transitions healthcare must encounter; “Episodic to Continuous”, “Provider care to Patient centric”, “Fragmented to Connected”, and “Volume to Value”.
Describing it as “strange”, Mr. Tas elaborated particularity of healthcare and its obstacles, which can be overcome by use of technology. One critical point indicated was that healthcare is organized around providers while other industries are organized around consumers. He expressed further need of shift to “patient centric”. In addition, medical system needs to shift away from fee-for-service payment models and transform to be more preventive and cost effective. Having daughter with diabetes type 1, Mr. Tas promoted personalized care for each patient and his or her family.
In addition, Mr. Tas mentioned the current platform in the Netherlands by collaboration with the government and private sectors as a best practice of public private partnership for healthcare ICT.
After Mr. Tas’ presentation, he and experts from private, public and academic sectors had vibrant discussion and Q&A session to foster policy making in Japan.
Closing Remarks
Coucillor Michiyo Yakushiji closed the session, urging leadership of legislative body to overcome regulatory bottlenecks and facilitate building new technology from Japan.
Exhibition date:2016-04-27
Top Research & Recommendations Posts
- [Public Comment Submission] “The 7th Science, Technology and Innovation Basic Plan” (Draft) (February 19, 2026)
- [Research Report] Energy Conservation and Greenhouse Gas Emissions Reduction in Healthcare Facilities: Case Studies from New Construction and Facility Renewal (March 16, 2026)
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Policy Recommendations] Policy Recommendations in the Field of Blood Disorders “Building a Healthcare Ecosystem Centered on Patients and Those Affected” (April 13, 2026)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Event Report and Discussion Points] AI Diagnostic Support Project Expert Meeting: “The Roles of Industry, Government, Academia, and Civil Society in the Era of AI-Assisted Diagnosis” (May 25, 2026)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Policy Recommendations] Dementia Project “The Future of Dementia Policy Surrounding Families and Others Who Care for People with Dementia” (April 27, 2026)
- [Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)
- [Research Report] The 2026 Public Opinion Survey on Healthcare in Japan (February 13, 2026)
Featured Posts
-
2026-05-13
[Registration Open] HGPI Salon 2025-2026 Looking Ahead to the Future of Japan’s Social Security System “Session 5: The Value of Healthcare in Society – Perspectives from the Reiwa Era” (June 29, 2026)
-
2026-05-15
[Registration Open] (Webinar) The 2nd J-PEP Seminar – A New Framework for Providing Information on Clinical Trial Participant Recruitment – Legal Points to Consider from the Perspective of Meaningful Involvement (June 15, 2026)
-
2026-05-18
[Registration Closed] Kick-off Panel Discussion “From Africa and Japan, Drawing from Perspectives Around the World:A Platform for Cultivating a Philosophical Health Dialogue Together” (June 15, 2026)
-
2026-05-19
[Registration Open] (Webinar) HGPI Special Seminar “Building a Society Where People Live with Blood Disorders: The Future of Blood Disorder Policy as Examined from the Frontlines of Home-Based Care × Lived Experience Research” (June 12, 2026)
-
2026-06-04
[Registration Open] (Webinar) The 3rd J-PEP Seminar “Social Participation of People with Intractable Diseases and the Potential of a New Way of Working — ‘RD Workers’ — Lessons from Policy Advocacy Practice” (July 22, 2026)



